GEN1047: An investigational ImmTAC targeting the B7H4 immune checkpoint protein on cancer cells, showing promising preclinical activity in ovarian cancer models and has entered clinical testing​​.

IMA402: Targets the PRAME protein and has demonstrated clinical activity against several solid tumor types, including lung, ovarian, uterine, skin, and synovial cancers​​.
